NM_003361.4:c.744C>G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_003361.4(UMOD):c.744C>G(p.Cys248Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C248R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003361.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant medullary cystic kidney disease with or without hyperuricemiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- glomerulocystic kidney disease with hyperuricemia and isosthenuriaInheritance: AD Classification: DEFINITIVE Submitted by: Laboratory for Molecular Medicine
- familial juvenile hyperuricemic nephropathy type 1Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant medullary cystic kidney disease with hyperuricemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_003361.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| UMOD | NM_003361.4 | MANE Select | c.744C>G | p.Cys248Trp | missense | Exon 3 of 11 | NP_003352.2 | ||
| UMOD | NM_001378234.1 | c.744C>G | p.Cys248Trp | missense | Exon 3 of 12 | NP_001365163.1 | |||
| UMOD | NM_001378235.1 | c.744C>G | p.Cys248Trp | missense | Exon 3 of 12 | NP_001365164.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| UMOD | ENST00000396138.9 | TSL:5 MANE Select | c.744C>G | p.Cys248Trp | missense | Exon 3 of 11 | ENSP00000379442.5 | ||
| UMOD | ENST00000396134.6 | TSL:2 | c.843C>G | p.Cys281Trp | missense | Exon 4 of 12 | ENSP00000379438.2 | ||
| UMOD | ENST00000570689.5 | TSL:5 | c.744C>G | p.Cys248Trp | missense | Exon 3 of 11 | ENSP00000460548.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects UMOD function (PMID: 23988501). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 287876). This sequence change replaces cysteine, which is neutral and slightly polar, with tryptophan, which is neutral and slightly polar, at codon 248 of the UMOD protein (p.Cys248Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with UMOD-related conditions (PMID: 14531790, 17245395, 23988501). It has also been observed to segregate with disease in related individuals. This variant is also known as C849G.
UMOD-related disorder Pathogenic:1
The UMOD c.744C>G variant is predicted to result in the amino acid substitution p.Cys248Trp. This variant has reported in several individuals in families with uromodulin-associated kidney disease (Wolf et al. 2003. PubMed ID: 14531790; Wolf et al. 2007. PubMed ID: 17245395; family F2, Liu et al. 2013. PubMed ID: 23988501; ID: F9, Gong et al. 2021. PubMed ID: 33574344). Immunofluorescence studies demonstrate that expression of this variant affects uromodulin intracellular trafficking (Liu et al. 2013. PubMed ID: 23988501). This variant has not been reported in a large population database, indicating this variant is rare. Additionally, a different missense change impacting the same amino acid (p.Cys248Ser) has been reported in members of a family with uromodulin-associated kidney disease (family F6, Zaucke et al. 2010. PubMed ID: 20172860). Taken together, the p.Cys248Trp variant is interpreted as pathogenic.
Familial juvenile hyperuricemic nephropathy type 1 Other:1
Possible association with Later onset of ESRD
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at